FDA panel unanimously backs Celltrion's Rituxan biosimilar

10th October 2018 Uncategorised 0

An independent panel of FDA advisors endorsed Celltrion’s Rituxan biosimilar, sending the program to the FDA for a final say.

More: FDA panel unanimously backs Celltrion's Rituxan biosimilar
Source: fierce